Per Eystein Lønning

BRCA1 Methylation in Circulating Free DNA: A Constitutional Matter?

Per Eystein Lønning, Stian Knappskog

no (code pays fourni par la source)

Improving Survival Models in Health Care by Balancing Imbalanced Cohorts: A Novel Approach

Catherine Ning, Dimitris Bertsimas, Per Eystein Lønning, Federico N. Auecio et autres

us, no, de, nl, jp, fr (code pays fourni par la source)

Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study

Christina Engebrethsen, Synnøve Yndestad, Emiel A. M. Janssen, Bjørnar Gilje et autres

no (code pays fourni par la source)

Triple-Negative Breast Cancer on the Rise or…? [Letter]

Per Eystein Lønning, Oleksii Nikolaienko, Stian Knappskog

no (code pays fourni par la source)

471P Impact of TP53 and HRD status on 5-year survival in TNBC treated with sequential neoadjuvant olaparib and high-dose cyclophosphamide/carboplatin (the PETREMAC trial)

Morten Rasmussen, Synnøve Yndestad, Hanna Dillekås, Christina Engebrethsen et autres

no (code pays fourni par la source)

Abstract LB308: Rewiring of methylation during embryogenesis can seed cancer decades later

Lori D. Kregar, Joe Lee, Michael Spencer Chapman, Oleksii Nikolaienko et autres

gb, no, pa (code pays fourni par la source)

Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer” by Y. Chen et al.

Per Eystein Lønning, Oleksii Nikolaienko, Stian Knappskog

no (code pays fourni par la source)

Constitutional Epimutations: From Rare Events Toward Major Cancer Risk Factors?

Per Eystein Lønning, Oleksii Nikolaienko, Stian Knappskog

no (code pays fourni par la source)

Germline variants in CDKN2A wild‐type melanoma prone families

Gjertrud T. Iversen, Marie Loeng, A. Holth, Per Eystein Lønning et autres

no (code pays fourni par la source)

The impact of functional MDM2-polymorphisms on neutrophil counts in breast cancer patients during neoadjuvant chemotherapy

Nora D. Hatletvedt, Christina Engebrethsen, Jürgen Geisler, Stephanie Geisler et autres

no (code pays fourni par la source)

MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas

Oleksii Nikolaienko, Garnet L. Anderson, Rowan T. Chlebowski, Su Yon Jung et autres

no, us (code pays fourni par la source)

Author response for "Germline variants in CDKN2A wild‐type melanoma prone families"

Gjertrud T. Iversen, Marie Loeng, A. Holth, Per Eystein Lønning et autres